Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,852Revenue (TTM) $M1,029Net Margin (%)6.4Altman Z-Score3.1
Enterprise Value $M3,412EPS (TTM) $1.2Operating Margin %11.0Piotroski F-Score7
P/E(ttm)47.0Beneish M-Score-2.5Pre-tax Margin (%)7.1Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %--Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow46.8y-y EBITDA Growth Rate %11.0ROA % (ttm)4.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)9.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M51.0ROIC % (ttm)7.9Gross Margin Increase y-yN

Gurus Latest Trades with NUVA

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

NUVA is held by these investors:

NUVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LUCIER GREGORY TChairman & CEO 2017-08-29Buy2,000$61.52-9.82view
HOWE LESLEY HDirector 2017-08-18Sell3,970$64.64-14.17view
LUCIER GREGORY TChairman & CEO 2017-08-17Buy5,000$66.22-16.22view
Leddy Peter MichaelEVP Global HR 2017-08-01Buy7,850$63.88-13.15view
Miles PatrickDirector 2017-06-07Sell15,000$78.35-29.19view
Hannon JasonPresident and COO 2017-03-08Sell24,840$74.22-25.25view
HOWE LESLEY HDirector 2017-02-14Sell6,049$73.26-24.27view
LUCIER GREGORY TChairman & CEO 2017-02-14Sell17,286$72.78-23.77view
Link MatthewPresident, U.S. Commercial 2016-12-12Sell10,303$67.99-18.4view
OHALLERAN MICHAEL DDirector 2016-11-04Buy4,200$58.26-4.77view

Press Releases about NUVA :

Quarterly/Annual Reports about NUVA:

News about NUVA:

Articles On GuruFocus.com
Research Report Identifies Hill-Rom, TASER International, Synchronoss Technologies, NuVasive, Verast Nov 20 2017 
NuVasive To Participate In The 29th Annual Piper Jaffray Healthcare Conference Nov 16 2017 
NuVasive Announces $100 Million Share Repurchase Program Oct 24 2017 
NuVasive Extends Its Leadership As Lateral Spine Technology Innovator With New Lateral Single-Positi Oct 23 2017 
NuVasive Launches New 3D-Printed Porous Titanium Implant In Expanding Advanced Materials Science Por Oct 18 2017 
NuVasive Receives Expanded FDA 510(k) Clearance For TLX Interbody System Used In TLIF Procedures Oct 16 2017 
NuVasive Receives Expanded FDA 510(k) Clearance For Innovative Magnetic Limb Lengthening Technology Oct 12 2017 
Alphatec Denounces “Baseless” NuVasive Complaint Oct 11 2017 
Nuvasive Files Lawsuit Against Patrick S. Miles To Protect Corporate Assets And Stakeholders' Intere Oct 10 2017 
Nuvasive Announces Conference Call And Webcast Of Third Quarter 2017 Results Oct 05 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat